Building the Strategic Communications Roadmap

Donna L. LaVoiePresident & CEO, LaVoieHealthScience

2019 Communications ObjectivesExample

2

1. Build visibility in the local biotechnology ecosystem, general biotechnology industry, and gene therapy community through earned media coverage

2. Support publicity initiatives surrounding key conferences and collaborations

3. Ramp up volume of original content, further establishing thought-leadership through blog topics and industry insights as well as leveraging social media to amplify reach

4. Start pre-IPO planning—what we need to do to start looking like a public company

Investors

Business & Partnership

Opportunities

Patients/Advocacy

Physicians/KOLs

Government & Regulatory Agencies

Health & Life Science Industry

Conference Support

4

• Strategic Counsel

• Message Development

• External Relations

– Meeting making

– Media interviews

– Partnering portal support

– Panel opportunities and keynotes

– Onsite support TBD

– Investor and business development introductions

• Other Conferences to Consider

– Medical Congresses• Gene Therapy for Rare Disorders, Boston, 3/26-28

• The Cell & Gene Meeting on the Mediterranean,

Barcelona, 4/29-5/2

• Neurodegenerative Drug Development –

Focus on Gene Therapy, Parish, 5/21-23

• Annual Conference of the British Society for

Gene and Cell Therapy, Sheffield, 6/25-26

• Cell & Gene Therapy Manufacturing and

Commercialization, Boston, 9/10-13

• CAR-TCR Summit, Boston, 10/9

• Cell & Gene Therapy Strategy Meeting Europe,

Zurich, 10/21-25

– Partnering/Investor Conferences• World Orphan Drug Congress, Maryland, 4/10-4/12

• BioCentury Future Leaders, New York, 4/12

• BioTrinity - European Biopartnering and Investment

Conference 2019, London, 4/30-5/1

• Bio€quity Europe 2019, Barcelona, 5/20-21

• BioCentury Newsmakers, New York, 9/1

• BIO Investor Forum, San Francisco, 10/22-23

• BIO CEO & Investor Conference, New York, 2/10-11

Expanding Your Investor Base:

LHS ReachTM

Paul SaganAVP, Investor Relations & Corporate Communications, LaVoieHealthScience

6

LHS Reach™ Methodology

Engaging with Investors & Partners

Mark MonanePrincipal & Chief Medical Officer Monane Clinical Consulting, LLC

8

Monane Group Clinical Consulting, LLC

Company management teams say the darnest things….

• Things we like to hear from management teams…• References to previous presentations/decks

• Limitations of study design and approach

• Comments from team members other than the CEO

• Things we don’t like to hear…• “We’re under the radar…”

• “We are thinking about …”

• “You love company X, so you cannot like us…”

Building Value:

Managing Media & Social Media

Angus McQuilkenBusiness Development Manager, Life SciencesMcDermott, Will & Emory

Sharon CorreiaSenior Vice President, Integrated Communications

LaVoieHealthScience

BIO International 2019Building the Strategic RoadmapHow Can Brand

Exposure Impact

Investor

Sentiment?

BIO International 2019Building the Strategic Roadmap

What’s News and What’s

Not - Recent Headlines